Dividends4Life: Abbvie Inc. (ABBV) Trading At A Deep Discount, But With Risks

Abbvie Inc. (ABBV) Trading At A Deep Discount, But With Risks

Posted by D4L | Thursday, November 06, 2014 | | 0 comments »

Linked here is a detailed quantitative analysis of Abbvie Inc. (ABBV). Below are some highlights from the above linked analysis:

Company Description: Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis.

Read More...

________________________________________________________________

0 comments

Post a Comment

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)